Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 30;39(1):204.
doi: 10.1186/s13046-020-01709-5.

The role of microenvironment in tumor angiogenesis

Affiliations
Review

The role of microenvironment in tumor angiogenesis

Xianjie Jiang et al. J Exp Clin Cancer Res. .

Abstract

Tumor angiogenesis is necessary for the continued survival and development of tumor cells, and plays an important role in their growth, invasion, and metastasis. The tumor microenvironment-composed of tumor cells, surrounding cells, and secreted cytokines-provides a conducive environment for the growth and survival of tumors. Different components of the tumor microenvironment can regulate tumor development. In this review, we have discussed the regulatory role of the microenvironment in tumor angiogenesis. High expression of angiogenic factors and inflammatory cytokines in the tumor microenvironment, as well as hypoxia, are presumed to be the reasons for poor therapeutic efficacy of current anti-angiogenic drugs. A combination of anti-angiogenic drugs and antitumor inflammatory drugs or hypoxia inhibitors might improve the therapeutic outcome.

Keywords: Angiogenic factor; Hypoxia inhibitor; Inflammatory factor; Tumor angiogenesis; Tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The role of hypoxia in tumor angiogenesis. a Under normoxic conditions, HIF-1α and HIF-2α are hydroxylated by PHDs and FIH-1. Subsequently, pVHL can recognize and ubiquitinate hydroxylated HIF-1α/HIF-2α and degrade them via proteasome-mediated degradation. b Under hypoxic conditions, the inactivation of FIH-1 and PHDs cannot hydroxylate HIF-1/HIF-2α, decreases HIFα-VHL binding, and promotes the formation of HIFα-HIFβ dimers that enter the nucleus to activate downstream targets. HIF-1α/HIF-2α can activate EphA1, ANGPT, VEGFA, VEGFR1, and other angiogenesis related genes to promote tumor angiogenesis. Alternatively, HIF-1α/HIF-2α can activate Claudin-4, Vimentin, LOXL2, Twist1, VE-cadherin to promote vasculogenic mimicry
Fig. 2
Fig. 2
Cytokines and cell growth factors secreted in the tumor microenvironment
Fig. 3
Fig. 3
Schematic representation of key VEGF/VEGFR signal transduction pathways. Proliferation: VEGFR can interact with Grab/Src/Gab1/Shb/PKCγ to activate RAF/MEK/MAPK and PI3K/AKT signaling pathways, and promote the proliferation of endothelial cells. Migration and invasion: VEGFR can activate PI3K/AKT by binding to cdc42, Rho, and RacGTPases, and promotes the migration and invasion of endothelial cells. Permeability: VEGFR can enhance blood vessel permeability by activating NFAT/β-catenin/VE-cadherin, and eNOS. Vasculogenic mimicry: VEGFR can promote EMT-induced vasculogenic mimicry by upregulating the expression of EMT-related genes
Fig. 4
Fig. 4
The regulatory network of tumor angiogenesis in the tumor microenvironment
Fig. 5
Fig. 5
Role of non-coding RNA in regulating tumor angiogenesis

References

    1. Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. Tumor Angiogenesis and anti-angiogenic strategies for cancer treatment. J Clin Med. 2019;9(1):81. doi: 10.3390/jcm9010084. - DOI - PMC - PubMed
    1. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1–8. doi: 10.1056/NEJM199101033240101. - DOI - PubMed
    1. Cao Y. Tumor angiogenesis and molecular targets for therapy. Front Biosci (Landmark Ed) 2009;14:3962–73. doi: 10.2741/3504. - DOI - PubMed
    1. Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011;12(9):551–64. doi: 10.1038/nrm3176. - DOI - PMC - PubMed
    1. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307. doi: 10.1038/nature10144. - DOI - PMC - PubMed

MeSH terms

Substances